Maqameh and Picaresque: Is picaresque influenced by Maqameh?‎

Centuries after Maqameh had come to the fore, stories by the name of ''Picaresque'' began to be written in Spanish literature which had numerous similarities with Maqameh. Picaresque can be regarded as the evolutional forms of romances with a different subject matter. Lazarillo de Tormes is the first picaresque story which has been written in 16th century in Spain. Narratives of picaresque have numerous similarities with present-day stories, so much so that, some designate Don Quixote de la Mancha- one of the latest picaresque- as the first novel. Since Spain was conquered by Umayyad dynasty, connections were formed between Arabs and Spanish which lead to scientific, artistic, and cultural exchanges and bilateral use of cultural resources. Since picaresque was formed in Spain and because of its similarities to Maqameh, the hypothesis comes to the fore that it originates from Maqameh. This has been referred to in some works which we have made mention of them in the literature. However, we oppose this hypothesis by showing their differences and foregrounds of Picaresque in Europe as well as its social-historical factors. In 4th Islamic centuries, a species of prose came to the fore in Arab literature which was called Maqamat. It rapidly gained prominence because Arabic prose in this era had been tended to decorum and artifice and the appearance of Picaresque paved the way for the pens who adored artifice. Mohammad Taghi Bahar believed that Maqameh was a translation of "Gath'' in Mazdayasna (Zoroastrianism) which has survived after Islam. These excerpts in Mazdayasna were melodious and its syllabic poems had symmetry, balance and interval silences; just how Maqamat seems to be (Bahar, 1349, 2nd v: 234). Picaresque was a story written by a picaro in which a satire of his era and the people is narrated (Sibre, 1389:4). This literary genre appeared in 16th century in Spain and spread to other European countries like France, Italy, Germany, and England. The myth of Hermes can be regarded as the prototype of picaro. According to Greek myths, he was the god of roads, commerce, fortune, sports, and rhetoric. Hermes used to deceive people and trickery was one of his features (Manser, 2009: 219). Picaresque can also be a mixture of "picaro", "picador", "Picards", and "picaroon". Maqamat in its theme is influenced by the social and cultural situation of its era. Beggary, deceit, and tongue are some common themes of Maqamat which is a mirror of the social and cultural situation of that time. Picaresque is in its turn a micro history conflated of literary and historical narratives which its roots should be sought in humanism (De Haan and Mierau, 2014: 1-2). Since picaresque has come to the fore because of a protest to the feudalism of Spain in 16th c and the quasi- religious reign of the era, has been labeled as humanistic works. Considering similarities of Maqameh and picaresque, the appearance of Maqameh six century before picaresque and in Spain, the hypothesis has taken some force because Arabs lived and ruled Spain in that period and the bilateral relationships of them cannot be neglected. Nonetheless, these similarities do not provide a solid ground for the hypothesis because these similarities are there in postmodernism, symbolism and Persian classic literature. In addition to differences between the two which outnumbers their similarities, the second reason to reject the hypothesis is the fact that picaresque came into the fore influenced by a foreground of European story writing, holy Books, romance, Aesop's fables, The Fabliau, joke books, novella, and etc. the third reason is the social-cultural condition of Spain in 16th centuries and the influence of the life of picaro, Picards, picaroon; just as the influence of the rhythmic style of Quran and traditions of Abu-Zayd Sorooji, Abbas doos, Tarrar Basrah is evident. Furthermore, the fact is that picaresque was not directly influenced by Maqameh because of the three explicit intertextual relationships (quotations, plagiarism, and implicit intertextuality), none can be trace in picaresque from Maqameh. Picaresque should be considered as the product of Spanish social condition of that period of time, not an imitated one nor influenced by eastern prose. This story genre, indeed, was taken from the lives of the poor and picaro of that era of Spain which criticized feudalism, quasi-religious reign, and churches. It is a satire on the miserable state of the poor and their hopeless struggle for bread. At best, Maqameh can be considered as one of the foregrounds of picaresque

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

A Case Report of Muscle Hydatidosis from Iran

  Hydatid cyst is an important endemic zoonosis in Iran. It may be seen in various organs of body. Musculoskeletal system is rarely involved by hydatid cyst, the larval form of Echinococcus granulosus. On clinical basis, it may resemble any soft tissue tu-mor. A 70-years old housewife living in Ardoghesh, a village in Neyshabur, north-east Iran, was admitted to general surgery clinic because of a painless mass in the back of her left thigh. This case emphasizes that hydatidosis should be included in differential diagnosis of any soft tissue mass especially in regions where hydatidosis is endemic

Chemical/photochemical functionalization of polyethylene terephthalate fabric: effects on mechanical properties and bonding to nitrile rubber

Abstract The aim of this work is to compare the effects of chemical and photochemical functionalization on the mechanical properties of PET fabric and its adhesion to nitrile rubber (NBR). The photochemical functionalization was performed by UV irradiation of PET fabric in the presence of glutaric acid peroxide at a temperature of 60 °C for different exposure times (i.e. 60, 90 and 120 min). The chemical functionalization (i.e. hydrolysis) of PET fabrics was performed by NaOH solution at a temperature of 60 °C for different times (i.e. 60, 120, 240 and 360 min). The tensile properties of the functionalized fibers were also evaluated. The functionalized PETs were evaluated for H-pull and T-peel adhesion to NBR. It was found that both treatment methods created functional groups on the PET surface. However, carboxylation of PET under GAP/UV irradiation generated much more OH groups on the PET surface (i.e. 4.5 times). The hydrolysis of PET in NaOH solution for more than 60 min caused a significant decrement in the tensile strength contrary to carboxylation under GAP/UV irradiation. It was also found that pullout and T-peel adhesions to NBR decreased in the case of hydrolysis of PET while they increased about 33 and 12% for GAP/UV irradiated PET, respectively

Silanization of functionalized PET fabric to improve PET-nitrile rubber (NBR) adhesion; effects of functionalization type and silane concentration

Surface modification could increase affinity of PET fibers to polymer matrix by changing the interfacial physical interactions to covalent bonds. In this research, surface modification of a superfine polyethylene terephthalate (PET) fabric was performed by bis(triethoxysilylpropyl)tetrasulfide (TESPT). The surface grafting was performed at different silane concentrations (i.e. 1, 5 and 10X). Before silanization, the fabrics were functionalized using photochemical method (i.e. irradiation of UV light in presence of glutaric acid peroxide (GAP)) and also hydrolysis by Sodium hydroxide (NaOH). Due to functionalization, carboxyl and hydroxyl groups were formed on the PET surface that made it ready to condense with hydrolyzed silane molecules. The fabrics were characterized using FTIR, TGA, FE-SEM, XPS analysis for evaluation of grafting performances. XPS analysis confirmed the presence of new peaks of Si and S after surface modification with TESPT. Comparing the results of TESPT-grafted functionalized PETs, it was found that the silane grafting content on PET surface is dependent not only to the silane concentration but also to the functionalization method. Finally, the influences of silane grafting on the functionalized PET fabrics to NBR adhesion were evaluated using H-pull and T-peel tests. The results showed that silane grafted-carboxylated PET fabric illustrated more adhesion to NBR than silane grafted-hydroxylated PET (i.e. 33 and 12% improvement in the pullout strength and T-peel adhesion, respectively)

Co-Exposure Effects of LPS with Various Aflatoxin B1 Doses in Isolated Perfused Rat Liver Model

Background: Activation of inflammatory cells can cause more chemicals induced-hepatotoxicity. Aflatoxin B1 (AFB1) is a fungal toxin that induces acute hepatotoxicity in humans and animals. This study was conducted to examine the effect of co-exposure LPS and various aflatoxin B1 doses on the damage hepatic parameters in isolated perfused rat liver. Methods: Thirty-two male wistar rats (250-300g) were divided to eight groups including Control and LPS; three groups with various doses of AFB1 (0.01, 0.1 and 1 ppm) and three groups with various doses of AFB1 and Lipopolysaccharide (LPS) (300 ppm). Activity of Aspartate transaminase (AST) and Alanine transaminase (ALT) were determined in perfusate. Thiobarbituric acid reactive substances (TBARS) and Glutathione (GSH) concentrations were measured in homogenate liver. Results: At two groups of AFB 1 (with LPS and without LPS) at AFB1 concentrations of 0.1 and 1 ppm, elevation of AST and ALT enzymes activity were indicated. Values of GSH in both of groups (AFB 1 with LPS and without LPS) had reduced at concentration of 1 ppm. TBARS concentrations were enhanced in AFB1 concentration of 1 ppm in both of groups (with LPS and without LPS), however in comparison between groups (with LPS and without LPS) in similar concentrations significant different did not observe (P<0.05). Conclusion: Non-injurious dose of LPS did not enhance liver susceptibility to various doses of AFB1 in perfused rat liver. This may be in part of due to extrahepatic factors, which contribute, in more liver damage

The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease StudyResearch in context

Summary: Background: The objective of this study is to investigate the trends of exposure and burden attributable to the four main metabolic risk factors, including high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body-mass index (BMI), and high low-density lipoproteins cholesterol (LDL) in North Africa and the Middle East from 1990 to 2019. Methods: The data were retrieved from Global Burden of Disease Study 2019. Summary exposure value (SEV) was used for risk factor exposure. Burden attributable to each risk factor was incorporated in the population attributable fraction to estimate the total attributable deaths and disability-adjusted life-years (DALYs). Findings: While age-standardized death rate (ASDR) attributable to high-LDL and high-SBP decreased by 26.5% (18.6–35.2) and 23.4% (15.9–31.5) over 1990–2019, respectively, high-BMI with 5.1% (−9.0–25.9) and high-FPG with 21.4% (7.0–37.4) change, grew in ASDR. Moreover, age-standardized DALY rate attributed to high-LDL and high-SBP declined by 30.2% (20.9–39.0) and 25.2% (16.8–33.9), respectively. The attributable age-standardized DALY rate of high-BMI with 8.3% (−6.5–28.8) and high-FPG with 27.0% (14.3–40.8) increase, had a growing trend. Age-standardized SEVs of high-FPG, high-BMI, high-SBP, and high-LDL increased by 92.4% (82.8–103.3), 76.0% (58.9–99.3), 10.4% (3.8–18.0), and 5.5% (4.3–7.1), respectively. Interpretation: The burden attributed to high-SBP and high-LDL decreased during the 1990–2019 period in the region, while the attributable burden of high-FPG and high-BMI increased. Alarmingly, exposure to all four risk factors increased in the past three decades. There has been significant heterogeneity among the countries in the region regarding the trends of exposure and attributable burden. Urgent action is required at the individual, community, and national levels in terms of introducing effective strategies for prevention and treatment that account for local and socioeconomic factors. Funding: Bill &amp; Melinda Gates Foundation

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019Research in context

Summary: Background: The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019. Methods: We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends. Findings: In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR. Interpretation: The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rheumatoid arthritis and upsurging new cases of other five IMIDs, respectively. Funding: The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The project funded by Scientific Research Fund of Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital (2022QN38)